Stomach Cancer Trial, Recruiting NCT05722275 Sponsor: Chinese Academy of Sciences Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT05722275
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with advanced stomach cancer (at a stage of cT3 or higher), confirmed through a tissue sample taken during a camera examination of the stomach, along with a CT scan and/or an internal ultrasound.
  • People who have had both a CT scan with contrast dye and a keyhole surgical procedure (laparoscopy) to examine the inside of the abdomen.
  • People whose CT scan does not show clear signs of cancer spreading to the lining of the abdomen — for example, no widespread nodules on the fatty tissue covering the organs, no large amounts of fluid in the abdomen, and no obvious irregular thickening of the abdominal lining.
  • People whose CT scan shows no signs of the cancer spreading to distant parts of the body, and no features of stage IV cancer.

Who may not be able to join:

  • People who have previously had surgery on their abdomen.
  • People who have previously had cancer or an inflammatory disease affecting the abdomen.
  • People where the CT scan and the laparoscopy procedure were done more than 2 weeks apart.
  • People whose CT scan images have quality problems (such as blurring or distortion) that make it difficult to properly assess the abdominal lining for signs of cancer spread.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 010-82618465

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Chinese Academy of Sciences
Registry
ClinicalTrials.gov
Start date
1 January 2023
Est. completion
31 December 2023

Where this trial is recruiting

🇨🇳 China 🇮🇹 Italy

Primary endpoints

The aera under the receiver operating characteristic curve (AUC) of intelligent analysis system

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov